<DOC>
	<DOCNO>NCT02766439</DOCNO>
	<brief_summary>March 2013 March 2014 , Rhupus patient enrol receive 25-mg etanercept injection subcutaneously twice week . The follow-up time study 24 week .</brief_summary>
	<brief_title>Rhupus Syndrome Efficacy Etanercept Treatment</brief_title>
	<detailed_description>March 2013 March 2014 , patient unresponsive therapy corticosteroid disease-modifying antirheumatic drug ( DMARDs ) , Disease Activity Score 28 Joints ( DAS28 ) &gt; 5.1 enrolled receive 25-mg etanercept injection subcutaneously twice week . The follow-up time study 24 week .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Rhupus patient unresponsive therapy corticosteroid diseasemodifying antirheumatic drug ( DMARDs ) , Disease Activity Score 28 Joints ( DAS28 ) &gt; 5.1 participated study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>